HOME >> MEDICINE >> NEWS
Liverpool study highlights national crisis in pathology

A study of the UK's pathologists, carried out by a scientist at the University of Liverpool on behalf of the Department of Health and the Royal College of Pathologists, has sparked concern over the numbers leaving the profession particularly in academia.

Pathologists are skilled scientists whose role is to identify the nature, origin and process of a disease. Professor Christopher Foster from the University's School of Cancer Studies carried out the audit of academic pathologists working in the UK and found that the number of academic pathologists has decreased by 40% in the past year alone. His research also indicated a decline in the number of UK students both in science and medicine - choosing to enter the profession.

The Department of Health has responded to the study by establishing new clinical roles and lecturing posts to fill the void left by the drop in practicing pathologists in the UK. In addition, cancer research charities are helping to set up new centres of cancer pathology training to recruit pathologists focused on cancer research.

Professor Foster, who is also Director of Workforce Planning at the Royal College of Pathologists, said: "The loss of working clinical academics is directly linked to the conflicting academic and service pressures they face, as well as staggering workloads. Additional pressure is felt in light of the upcoming Research Assessment Exercise (RAE) in which the quality of their research is assessed and reported to the four major higher education funding bodies on behalf of their individual university.

"Many academic pathologists consistently work in excess of 60 hours per week to meet their academic requirements while simultaneously dealing with NHS work lists at the same time. Although academic with clinical commitments find it difficult to compete against full-time medical researchers, their knowledge and understanding is of fundamental importance to a wide spectrum of clinical
'"/>

Contact: Joanna Robotham
joanna.robotham@liv.ac.uk
44-151-794-2026
University of Liverpool
8-Mar-2006


Page: 1 2

Related medicine news :

1. Liverpool launches 20 million project to develop medicines for children
2. World leaders in cancer research to meet in Liverpool
3. Liverpool psychology helps bring peace to European football
4. Liverpool placenta study could save lives
5. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
6. Penn study finds pro-death proteins required to regulate healthy immune function
7. New study shows promise in reducing surgical risks associated with surgical bleeding
8. New study counts the economic cost of persistent pain in Australia
9. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
10. Most seniors now have drug coverage, U-M study shows
11. To gain muscle and lose fat, drink milk: study

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Liverpool study highlights national crisis pathology

(Date:6/19/2013)... (PRWEB) June 19, 2013 Kansas City will host ... Main Street Day . A section of Main Street in ... during the afternoon of the event. The Main Street Corridor ... event, which will help Kansas City join the ranks of dozens ... as a tool to foster community vibrancy and active lifestyles. , ...
(Date:6/19/2013)... In 2011, the value of the ... Generic drugs form the largest sector, accounting for nearly ... industry is a significant contributor to the local economy; ... Approximately 50% of the total domestic chemical industry output ... Galenika and Zdravlje Actavis are key participants in the ...
(Date:6/19/2013)... 19, 2013 Elsevier, a world-leading provider of ... announced today the publication of the National Osteoporosis ... management of osteoporosis in postmenopausal women and older ... Published in 2009 in Maturitas , the ... update is timely with an additional focus on ...
(Date:6/19/2013)... Next Thursday, June 27, 2013, ... organization, and Muzzy Lane Software , a ... the Games for Health community to their interactive ... toward students in grades 4-7 and designed to ... positive choices. The game is part of a ...
(Date:6/19/2013)... Maui'd Forever , Hawaii's premiere ... an effective and cost effective way to provide for ... up with Tom Barefoot’s Tours providing an activity agent ... Hawaii’s activities. , They have just released a new ... lowest prices on their Hawaii activities. , Maui’d ...
Breaking Medicine News(10 mins):Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 4Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 5Health News:Maui'd Forever Pleased to Offer Price Guarantee on Hawaii Activities 2
(Date:6/19/2013)... NESS ZIONA, Israel , ... today announced that results from a phase I study ... study in advanced Parkinson,s patients, of ND0612, were presented ... Movement Disorders. ND0612 is a proprietary levodopa/carbidopa liquid drug ... (SC) delivery patch that would maintain constant levodopa plasma ...
(Date:6/19/2013)... 19, 2013  This year alone, The Leukemia & ... projects with one goal in mind: Discovering lifesaving therapies ... Training" (TNT), a flagship LLS fundraising campaign and the ... marking its landmark 25 th anniversary. To date, ... in research to discover and deliver breakthrough cancer treatments ...
(Date:6/19/2013)... June 19, 2013   Life Technologies Corporation ... licensing agreement granting Suzhou Ribo Life Sciences (Ribo) ... therapeutics in China using ... proprietary siRNA molecules in combination with Invivofectamine® Rx ... human diseases with high unmet medical need in ...
Breaking Medicine Technology:NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 2Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 3Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 4Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 5Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4
Cached News: